- Report
- October 2024
- 190 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 194 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 196 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- May 2024
- 128 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 128 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- August 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- May 2024
- 160 Pages
Global
From €4717EUR$4,969USD£3,979GBP
From €7120EUR$7,500USD£6,006GBP
- Report
- May 2022
- 228 Pages
Global
From €2492EUR$2,625USD£2,102GBP
€4984EUR$5,250USD£4,204GBP
- Report
- June 2023
- 180 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- August 2024
- 80 Pages
Japan
From €3323EUR$3,500USD£2,803GBP
- Report
- October 2023
- 190 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- July 2022
- 100 Pages
Global
From €2611EUR$2,750USD£2,202GBP
- Report
- April 2023
- 115 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP

Thrombosis is a medical condition in which a blood clot forms in a blood vessel, obstructing the flow of blood. It is a major concern in hematology, as it can lead to serious complications such as stroke, heart attack, and pulmonary embolism. Treatment of thrombosis typically involves anticoagulants, which are drugs that reduce the ability of the blood to clot. In some cases, thrombolytic drugs may be used to dissolve the clot.
The thrombosis market is a rapidly growing segment of the hematology market, driven by the increasing prevalence of thrombosis and the development of new treatments. The market is expected to benefit from the introduction of novel drugs and therapies, as well as the increasing demand for better diagnosis and treatment of thrombosis.
Some of the major companies in the thrombosis market include Bayer AG, Pfizer Inc., Sanofi, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more